Suzanne L. Baker - Publications

Affiliations: 
2003 University of California, Berkeley, Berkeley, CA, United States 

135 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Denkinger M, Baker S, Inglis B, Kobayashi S, Juarez A, Mason S, Jagust W. Associations between regional blood-brain barrier permeability, aging, and Alzheimer's disease biomarkers in cognitively normal older adults. Plos One. 19: e0299764. PMID 38837947 DOI: 10.1371/journal.pone.0299764  0.303
2024 Sanabria Bohórquez SM, Baker S, Manser PT, Tonietto M, Galli C, Wildsmith KR, Zou Y, Kerchner GA, Weimer R, Teng E. Evaluation of partial volume correction and analysis of longitudinal [F]GTP1 tau PET imaging in Alzheimer's disease using linear mixed-effects models. Frontiers in Neuroimaging. 3: 1355402. PMID 38606196 DOI: 10.3389/fnimg.2024.1355402  0.371
2024 Fonseca CS, Baker SL, Dobyns L, Janabi M, Jagust WJ, Harrison TM. Tau accumulation and atrophy predict amyloid independent cognitive decline in aging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38334195 DOI: 10.1002/alz.13654  0.336
2024 Landau SM, Lee J, Murphy A, Ward TJ, Harrison TM, Baker SL, DeCarli C, Harvey D, Tosun D, Weiner MW, Koeppe RA, Jagust WJ. Individuals with Alzheimer's disease and low tau burden: Characteristics and implications. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38241084 DOI: 10.1002/alz.13609  0.333
2023 Blazhenets G, Soleimani-Meigooni DN, Thomas W, Mundada N, Brendel M, Vento S, VandeVrede L, Heuer HW, Ljubenkov P, Rojas JC, Chen MK, Amuiri AN, Miller Z, Gorno-Tempini ML, Miller BL, ... ... Baker SL, et al. [F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37918868 DOI: 10.2967/jnumed.123.265856  0.368
2023 Chen X, Toueg TN, Harrison TM, Baker SL, Jagust WJ. Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults. Annals of Neurology. PMID 37789559 DOI: 10.1002/ana.26813  0.351
2023 Han F, Lee J, Chen X, Ziontz J, Ward T, Landau SM, Baker SL, Harrison TM, Jagust WJ. Global brain activity and its coupling with cerebrospinal fluid flow is related to tau pathology. Biorxiv : the Preprint Server For Biology. PMID 37745434 DOI: 10.1101/2023.09.12.557492  0.308
2022 Harrison TM, Ward TJ, Murphy A, Baker SL, Dominguez PA, Koeppe R, Vemuri P, Lockhart SN, Jung Y, Harvey DJ, Lovato L, Toga AW, Masdeu J, Oh H, Gitelman DR, et al. Optimizing quantification of MK6240 tau PET in unimpaired older adults. Neuroimage. 119761. PMID 36455762 DOI: 10.1016/j.neuroimage.2022.119761  0.376
2022 Tissot C, Servaes S, Lussier FZ, Ferrari-Souza JP, Therriault J, Ferreira PCL, Bezgin G, Bellaver B, Teixeira Leffa D, Mathotaarachchi SS, Chamoun M, Stevenson J, Rahmouni N, Kang MS, Pallen V, ... ... Baker SL, et al. The association of age-related and off-target retention with longitudinal quantification of [F]MK6240 tau-PET in target regions. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 36396455 DOI: 10.2967/jnumed.122.264434  0.314
2022 Zhuang K, Chen X, Cassady KE, Baker SL, Jagust WJ. Metacognition, cortical thickness, and tauopathy in aging. Neurobiology of Aging. 118: 44-54. PMID 35868093 DOI: 10.1016/j.neurobiolaging.2022.06.007  0.313
2022 LaPoint MR, Baker SL, Landau SM, Harrison TM, Jagust WJ. Rates of β-amyloid deposition indicate widespread simultaneous accumulation throughout the brain. Neurobiology of Aging. 115: 1-11. PMID 35447369 DOI: 10.1016/j.neurobiolaging.2022.03.005  0.374
2022 Meyer PF, Ashton NJ, Karikari TK, Strikwerda-Brown C, Köbe T, Gonneaud J, Pichet Binette A, Ozlen H, Yakoub Y, Simrén J, Pannee J, Lantero-Rodriguez J, Labonté A, Baker SL, Schöll M, et al. Plasma p-tau231, p-tau181, PET biomarkers and cognitive change in older adults. Annals of Neurology. PMID 35084051 DOI: 10.1002/ana.26308  0.338
2022 Ciampa CJ, Parent JH, Harrison TM, Fain RM, Betts MJ, Maass A, Winer JR, Baker SL, Janabi M, Furman DJ, D'Esposito M, Jagust WJ, Berry AS. Associations among locus coeruleus catecholamines, tau pathology, and memory in aging. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35034099 DOI: 10.1038/s41386-022-01269-6  0.414
2021 Adams JN, Harrison TM, Maass A, Baker SL, Jagust WJ. Distinct factors drive the spatiotemporal progression of tau pathology in older adults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34965972 DOI: 10.1523/JNEUROSCI.1601-21.2021  0.353
2021 Teng E, Manser PT, Sanabria Bohorquez S, Wildsmith KR, Pickthorn K, Baker SL, Ward M, Kerchner GA, Weimer RM. Baseline [F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer's disease. Alzheimer's Research & Therapy. 13: 196. PMID 34852837 DOI: 10.1186/s13195-021-00937-x  0.391
2021 Ziontz J, Adams JN, Harrison TM, Baker SL, Jagust WJ. Hippocampal connectivity with retrosplenial cortex is linked to neocortical tau accumulation and memory function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34531286 DOI: 10.1523/JNEUROSCI.0990-21.2021  0.364
2021 Strom A, Iaccarino L, Edwards L, Lesman-Segev OH, Soleimani-Meigooni DN, Pham J, Baker SL, Landau S, Jagust WJ, Miller BL, Rosen HJ, Gorno-Tempini ML, Rabinovici GD, La Joie R. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease. Brain : a Journal of Neurology. PMID 34373896 DOI: 10.1093/brain/awab294  0.439
2021 Baker SL, Provost K, Thomas W, Whitman AJ, Janabi M, Schmidt ME, Timmers M, Kolb HC, Rabinovici GD, Jagust WJ. Evaluation of [F]-JNJ-64326067-AAA tau PET tracer in humans. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211031035. PMID 34259071 DOI: 10.1177/0271678X211031035  0.396
2021 Ossenkoppele R, Smith R, Mattsson-Carlgren N, Groot C, Leuzy A, Strandberg O, Palmqvist S, Olsson T, Jögi J, Stormrud E, Cho H, Ryu YH, Choi JY, Boxer AL, Gorno-Tempini ML, ... ... Baker S, et al. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging. Jama Neurology. PMID 34180956 DOI: 10.1001/jamaneurol.2021.1858  0.305
2021 Edwards L, La Joie R, Iaccarino L, Strom A, Baker SL, Casaletto KB, Cobigo Y, Grant H, Kim M, Kramer JH, Mellinger TJ, Pham J, Possin KL, Rosen HJ, Soleimani-Meigooni DN, et al. Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females. Neurobiology of Aging. 105: 86-98. PMID 34049062 DOI: 10.1016/j.neurobiolaging.2021.04.003  0.392
2021 Cassady KE, Adams JN, Chen X, Maass A, Harrison TM, Landau S, Baker S, Jagust W. Alzheimer's Pathology Is Associated with Dedifferentiation of Intrinsic Functional Memory Networks in Aging. Cerebral Cortex (New York, N.Y. : 1991). PMID 34037210 DOI: 10.1093/cercor/bhab122  0.332
2021 Adams JN, Maass A, Berron D, Harrison TM, Baker SL, Thomas WP, Stanfill M, Jagust WJ. Reduced repetition suppression in aging is driven by tau-related hyperactivity in medial temporal lobe. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33731446 DOI: 10.1523/JNEUROSCI.2504-20.2021  0.375
2021 Provost K, La Joie R, Strom A, Iaccarino L, Edwards L, Mellinger TJ, Pham J, Baker SL, Miller BL, Jagust WJ, Rabinovici GD. Crossed cerebellar diaschisis on F-FDG PET: Frequency across neurodegenerative syndromes and association with C-PIB and F-Flortaucipir. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211001216. PMID 33691512 DOI: 10.1177/0271678X211001216  0.315
2021 Provost K, Iaccarino L, Soleimani-Meigooni DN, Baker S, Edwards L, Eichenlaub U, Hansson O, Jagust W, Janabi M, La Joie R, Lesman-Segev O, Mellinger TJ, Miller BL, Ossenkoppele R, Pham J, et al. Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33398408 DOI: 10.1007/s00259-020-05152-8  0.343
2020 Harrison TM, Du R, Klencklen G, Baker SL, Jagust WJ. Distinct effects of beta-amyloid and tau on cortical thickness in cognitively healthy older adults. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33325068 DOI: 10.1002/alz.12249  0.319
2020 Sonni I, Lesman Segev OH, Baker SL, Iaccarino L, Korman D, Rabinovici GD, Jagust WJ, Landau SM, La Joie R. Evaluation of a visual interpretation method for tau-PET with F-flortaucipir. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12133. PMID 33313377 DOI: 10.1002/dad2.12133  0.349
2020 La Joie R, Visani AV, Lesman-Segev OH, Baker SL, Edwards L, Iaccarino L, Soleimani-Meigooni DN, Mellinger T, Janabi M, Miller ZA, Perry DC, Pham J, Strom A, Gorno-Tempini ML, Rosen HJ, et al. Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET. Neurology. PMID 33262228 DOI: 10.1212/WNL.0000000000011270  0.386
2020 Chen X, Cassady K, Adams JN, Harrison TM, Baker SL, Jagust WJ. Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33219003 DOI: 10.1523/JNEUROSCI.2111-20.2020  0.387
2020 Yoon B, Baker SL, Korman D, Tennant VR, Harrison TM, Landau S, Jagust WJ. Conscientiousness is associated with less amyloid deposition in cognitively normal aging. Psychology and Aging. 35: 993-999. PMID 33166168 DOI: 10.1037/pag0000582  0.317
2020 Soleimani-Meigooni DN, Iaccarino L, La Joie R, Baker S, Bourakova V, Boxer AL, Edwards L, Eser R, Gorno-Tempini ML, Jagust WJ, Janabi M, Kramer JH, Lesman-Segev OH, Mellinger T, Miller BL, et al. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases. Brain : a Journal of Neurology. PMID 33141172 DOI: 10.1093/brain/awaa276  0.434
2020 Guo T, Korman D, Baker SL, Landau SM, Jagust WJ. Longitudinal Cognitive and Biomarker Measurements Support a Unidirectional Pathway in Alzheimer's Disease Pathophysiology. Biological Psychiatry. PMID 32919611 DOI: 10.1016/J.Biopsych.2020.06.029  0.421
2020 Winer JR, Mander BA, Kumar S, Reed M, Baker SL, Jagust WJ, Walker MP. Sleep Disturbance Forecasts β-Amyloid Accumulation across Subsequent Years. Current Biology : Cb. PMID 32888482 DOI: 10.1016/J.Cub.2020.08.017  0.307
2020 Iaccarino L, La Joie R, Edwards L, Strom A, Schonhaut DR, Ossenkoppele R, Pham J, Mellinger T, Janabi M, Baker SL, Soleimani-Meigooni D, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum. Cerebral Cortex (New York, N.Y. : 1991). PMID 32808011 DOI: 10.1093/Cercor/Bhaa184  0.51
2020 Cho SH, Choe YS, Kim HJ, Jang H, Kim Y, Kim SE, Kim SJ, Kim JP, Jung YH, Kim BC, Baker SL, Lockhart SN, Na DL, Park S, Seo SW. Correction to: A new Centiloid method for F-florbetaben and F-flutemetamol PET without conversion to PiB. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32055964 DOI: 10.1007/S00259-020-04692-3  0.32
2020 Pereira JB, Harrison TM, La Joie R, Baker SL, Jagust WJ. Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31915896 DOI: 10.1007/S00259-019-04669-X  0.403
2020 La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J, Chaudhary K, Edwards L, Iaccarino L, Janabi M, Lesman-Segev OH, Miller ZA, Perry DC, O'Neil JP, Pham J, et al. Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET. Science Translational Medicine. 12. PMID 31894103 DOI: 10.1126/Scitranslmed.Aau5732  0.494
2020 Soleimani‐Meigooni DN, Iaccarino L, La Joie R, Baker SL, Bourakova V, Boxer AL, Edwards L, Eser RA, Tempini MLG, Jagust WJ, Janabi M, kramer JH, Lesman‐Segev OH, Mellinger TJ, Miller BL, et al. [ 18 F]Flortaucipir PET to autopsy pathology comparisons in Alzheimer’s disease and other neurodegenerative diseases Alzheimer's & Dementia. 16. DOI: 10.1002/ALZ.046262  0.303
2019 Cho SH, Choe YS, Kim HJ, Jang H, Kim Y, Kim SE, Kim SJ, Kim JP, Jung YH, Kim BC, Baker SL, Lockhart SN, Na DL, Park S, Seo SW. A new Centiloid method for F-florbetaben and F-flutemetamol PET without conversion to PiB. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31834446 DOI: 10.1007/S00259-019-04596-X  0.328
2019 Harrison TM, Maass A, Adams JN, Du R, Baker SL, Jagust WJ. Tau deposition is associated with functional isolation of the hippocampus in aging. Nature Communications. 10: 4900. PMID 31653847 DOI: 10.1038/S41467-019-12921-Z  0.371
2019 Adams JN, Maass A, Harrison TM, Baker SL, Jagust WJ. Cortical tau deposition follows patterns of entorhinal functional connectivity in aging. Elife. 8. PMID 31475904 DOI: 10.7554/Elife.49132  0.451
2019 Teng E, Ward M, Manser PT, Sanabria-Bohorquez S, Ray RD, Wildsmith KR, Baker S, Kerchner GA, Weimer RM. Cross-sectional associations between [F]GTP1 tau PET and cognition in Alzheimer's disease. Neurobiology of Aging. 81: 138-145. PMID 31280117 DOI: 10.1016/j.neurobiolaging.2019.05.026  0.409
2019 Winer JR, Mander BA, Helfrich RF, Maass A, Harrison TM, Baker SL, Knight RT, Jagust WJ, Walker MP. Sleep as a potential biomarker of tau and β-amyloid burden in the human brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31209175 DOI: 10.1523/Jneurosci.0503-19.2019  0.354
2019 Shokouhi S, Conley AC, Baker SL, Albert K, Kang H, Gwirtsman HE, Newhouse PA. The relationship between domain-specific subjective cognitive decline and Alzheimer's pathology in normal elderly adults. Neurobiology of Aging. 81: 22-29. PMID 31207466 DOI: 10.1016/J.Neurobiolaging.2019.05.011  0.452
2019 Maass A, Berron D, Harrison TM, Adams JN, La Joie R, Baker S, Mellinger T, Bell RK, Swinnerton K, Inglis B, Rabinovici GD, Düzel E, Jagust WJ. Alzheimer's pathology targets distinct memory networks in the ageing brain. Brain : a Journal of Neurology. PMID 31199481 DOI: 10.1093/Brain/Awz154  0.487
2019 Ossenkoppele R, Iaccarino L, Schonhaut DR, Brown JA, La Joie R, O'Neil JP, Janabi M, Baker SL, Kramer JH, Gorno-Tempini ML, Miller BL, Rosen HJ, Seeley WW, Jagust WJ, Rabinovici GD. Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain. Neuroimage. Clinical. 23: 101848. PMID 31077982 DOI: 10.1016/J.Nicl.2019.101848  0.466
2019 Baker SL, Harrison TM, Maaß A, La Joie R, Jagust W. Effect of off-target binding on F-Flortaucipir variability in healthy controls across the lifespan. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30877180 DOI: 10.2967/Jnumed.118.224113  0.405
2019 Tsai RM, Bejanin A, Lesman-Segev O, LaJoie R, Visani A, Bourakova V, O'Neil JP, Janabi M, Baker S, Lee SE, Perry DC, Bajorek L, Karydas A, Spina S, Grinberg LT, et al. F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. Alzheimer's Research & Therapy. 11: 13. PMID 30704514 DOI: 10.1186/S13195-019-0470-7  0.485
2019 Adams JN, Maass A, Harrison TM, Baker SL, Jagust WJ. Author response: Cortical tau deposition follows patterns of entorhinal functional connectivity in aging Elife. DOI: 10.7554/Elife.49132.026  0.33
2019 Harrison TM, Becerra M, Winer JR, Baker SL, Grothe MJ, Jagust WJ. O4-12-02: Tau Pathology And Cognition Are Related To Basal Forebrain Degeneration In Aging Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4807  0.35
2019 Maass A, Harrison TM, Berron D, Adams JN, Joie RL, Baker SL, Düzel E, Jagust WJ. F4-02-02: Tau Pet Imaging In Aging: Contributions To Cognitive Decline And Neural Dysfunction Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4719  0.428
2019 Baker SL. F4-02-01: Trials And Tribulations Of Tau Pet Imaging Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4718  0.392
2019 Pereira JB, Harrison TM, Joie RL, Baker SL, Jagust WJ. Ic-P-172: Spatial Patterns Of Tau Deposition In Aging Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4287  0.332
2019 Baker SL, Joie RL, Liu C, Cobigo Y, Bourakova V, Harrison TM, Rabinovici GD, Jagust WJ. Ic-04-04: Iron, Neurodegeneration, Tau, And Amyloid In Patients With Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4154  0.389
2019 Soleimani-Meigooni DN, Iaccarino L, La Joie R, Lesman-Segev OH, Bourakova V, Strom A, Edwards L, Baker SL, Janabi M, Eser R, Larsen E, Spina S, Seeley WW, Grinberg LT, Jagust WJ, et al. P2-439: [18 F]FLORTAUCIPIR PET AND PATHOLOGY CORRELATIONS IN ALZHEIMER'S DISEASE, NON-ALZHEIMER'S TAUOPATHIES, AND OTHER NEURODEGENERATIVE DISEASES Alzheimer's & Dementia. 15: P782-P782. DOI: 10.1016/J.Jalz.2019.06.2846  0.47
2019 Harrison TM, Adams JN, Maass A, Du R, Baker SL, Jagust WJ. P2-353: Signal Coherence In The Hippocampus Is Related To Its Functional Isolation, Preclinical Alzheimer'S Disease Pathology And Memory In Aging Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2760  0.383
2019 Iaccarino L, Schonhaut DR, La Joie R, Ossenkoppele R, Bejanin A, Edwards L, Tammewar G, Pham JQ, Chaudhary K, Janabi M, Baker SL, Miller BL, Jagust WJ, Rabinovici GD. P2-336: SPATIAL DISTRIBUTION AND TOPOGRAPHICAL RELATIONSHIPS OF PATHOLOGY AND NEURODEGENERATION IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P720-P721. DOI: 10.1016/J.Jalz.2019.06.2743  0.373
2018 Harrison TM, La Joie R, Maass A, Baker SL, Swinnerton K, Fenton L, Mellinger TJ, Edwards L, Pham J, Miller BL, Rabinovici GD, Jagust WJ. Longitudinal tau accumulation and atrophy in aging and Alzheimer's disease. Annals of Neurology. PMID 30597624 DOI: 10.1002/Ana.25406  0.457
2018 He M, Baker SL, Shah VD, Lockhart SN, Jagust WJ. Scan-time Corrections for 80-100 Minute Standardized Uptake Volume Ratios to Measure the 18F-AV-1451 Tracer for Tau Imaging. Ieee Transactions On Medical Imaging. PMID 30235119 DOI: 10.1109/Tmi.2018.2870441  0.379
2018 Harrison TM, Maass A, Baker SL, Jagust WJ. Brain morphology, cognition, and β-amyloid in older adults with superior memory performance. Neurobiology of Aging. 67: 162-170. PMID 29665578 DOI: 10.1016/J.Neurobiolaging.2018.03.024  0.354
2018 Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O'Neil JP, Ossenkoppele R, et al. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease. Neuroimage. Clinical. 17: 452-464. PMID 29159058 DOI: 10.1016/J.Nicl.2017.09.016  0.493
2018 Harrison TM, Joie RL, Maass A, Baker SL, Rabinovici GD, Jagust WJ. O4-09-04: Longitudinal Tau-Pet And Atrophy In Healthy Older Adults And In Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2960  0.428
2018 Vogel JW, Ossenkoppele R, Kiar G, Medina YI, Baker SL, Hansson O, Evans AC, Initiative ADN. Ic-P-224: Heterogeneous Tau-Pet Signal In The Hippocampus Helps Resolve Discrepancies Between Imaging And Pathology Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2291  0.394
2018 Harrison TM, Joie RL, Maass A, Baker SL, Rabinovici GD, Jagust WJ. Ic-P-205: Longitudinal Tau-Pet And Atrophy In Healthy Older Adults And Those With Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2272  0.449
2018 Maass A, Berron D, Harrison TM, Baker SL, Mellinger TJ, Swinnerton KN, Bell RK, Düzel E, Jagust WJ, Adams JN. F1-04-04: Effects Of Tau And Amyloid Deposition Measured By Pet On Domain-Specific Memory Function In Old Age Alzheimers & Dementia. 14: 87. DOI: 10.1016/J.Jalz.2018.06.2167  0.434
2018 Sonni I, Lesman-Segev OH, Maass A, Baker SL, Korman D, Rabinovici GD, Jagust WJ. P2-373: Evaluation Of Visual Interpretation Methods For Tau Pet Imaging Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1064  0.37
2017 La Joie R, Bejanin A, Fagan AM, Ayakta N, Baker SL, Bourakova V, Boxer AL, Cha J, Karydas A, Jerome G, Maass A, Mensing A, Miller ZA, O'Neil JP, Pham J, et al. Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample. Neurology. PMID 29282337 DOI: 10.1212/Wnl.0000000000004860  0.398
2017 Winer JR, Maass A, Pressman P, Stiver J, Schonhaut DR, Baker SL, Kramer J, Rabinovici GD, Jagust WJ. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease. Jama Neurology. PMID 29228071 DOI: 10.1001/Jamaneurol.2017.3713  0.371
2017 Maass A, Lockhart SN, Harrison TM, Bell RK, Mellinger T, Swinnerton K, Baker SL, Rabinovici GD, Jagust WJ. Entorhinal tau pathology, episodic memory decline and neurodegeneration in aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29192126 DOI: 10.1523/Jneurosci.2028-17.2017  0.469
2017 Baker SL, Maass A, Jagust WJ. Considerations and code for partial volume correcting [(18)F]-AV-1451 tau PET data. Data in Brief. 15: 648-657. PMID 29124088 DOI: 10.1016/J.Dib.2017.10.024  0.431
2017 Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, O'Neil JP, Gorno-Tempini ML, Miller ZA, Rosen HJ, Miller BL, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease. Brain : a Journal of Neurology. PMID 29053874 DOI: 10.1093/Brain/Awx243  0.494
2017 Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, ... ... Baker SL, et al. (18) F-flortaucipir tau PET distinguishes established progressive supranuclear palsy from controls and Parkinson's disease: A multicenter study. Annals of Neurology. PMID 28980714 DOI: 10.1002/Ana.25060  0.424
2017 Maass A, Landau S, Baker SL, Horng A, Lockhart SN, Joie R, Rabinovici GD, Jagust WJ. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's Disease. Neuroimage. PMID 28587897 DOI: 10.1016/J.Neuroimage.2017.05.058  0.514
2017 Lockhart SN, Schöll M, Baker SL, Ayakta N, Swinnerton KN, Bell RK, Mellinger TJ, Shah VD, O'Neil JP, Janabi M, Jagust WJ. Amyloid and Tau PET Demonstrate Region-Specific Associations in Normal Older People. Neuroimage. PMID 28232190 DOI: 10.1016/J.Neuroimage.2017.02.051  0.463
2017 Marks SM, Lockhart SN, Baker SL, Jagust WJ. Tau and β-amyloid are associated with medial temporal lobe structure, function and memory encoding in normal aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28213439 DOI: 10.1523/Jneurosci.3769-16.2017  0.444
2017 Harrison TM, Lockhart SN, Baker SL, Jagust WJ. THE ROLE OF β-AMYLOID IN SUPERAGERS WITH SUPERIOR MEMORY PERFORMANCE AND PRESERVED BRAIN MORPHOMETRY Alzheimer's & Dementia. 13: P1463-P1464. DOI: 10.1016/J.Jalz.2017.07.532  0.308
2017 Lockhart SN, Adams JN, Baker SL, Kang J, Li L, Jagust WJ. EFFECTS OF TAU DEPOSITION ON CEREBRAL GLUCOSE METABOLISM IN NORMAL OLDER ADULTS VARY BY AMYLOID LEVEL Alzheimer's & Dementia. 13: P202. DOI: 10.1016/J.Jalz.2017.07.066  0.339
2017 La Joie R, Bourakova V, Visani A, Bejanin A, Ayakta N, Baker SL, Karydas A, Coppola G, Mensing A, Pham J, Rosen H, Miller BL, Jagust WJ, Rabinovici GD. [P1-414]: DOES APOE ε4 HAVE AN Aβ-INDEPENDENT EFFECT ON TAU PATHOLOGY? NEUROIMAGING INVESTIGATIONS IN COGNITIVELY NORMAL ELDERS AND PATIENTS WITH ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P435-P436. DOI: 10.1016/j.jalz.2017.06.430  0.347
2017 La Joie R, Visani A, Bourakova V, Baker SL, Ayakta N, Pham J, Mensing A, Rosen H, Miller BL, Jagust WJ, Rabinovici GD. [IC-01-01]: AV1451-PET CORTICAL UPTAKE AND REGIONAL DISTRIBUTION PREDICTS LONGITUDINAL ATROPHY IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P1-P1. DOI: 10.1016/J.Jalz.2017.06.2621  0.41
2017 La Joie R, Bejanin A, Fagan AM, Ayakta N, Baker SL, Bourakova V, Karydas A, Jerome G, O'Neil JP, Pham J, Visani A, Rosen H, Boxer A, Miller BL, Jagust WJ, et al. AV1451-PET UPTAKE AND CSF BIOMARKERS IN A HETEROGENEOUS CLINICAL SAMPLE: TWO SIDES OF THE SAME COIN? Alzheimer's & Dementia. 13: P137-P138. DOI: 10.1016/J.Jalz.2017.06.2561  0.309
2017 Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, O'Neil JP, Gorno-Tempini M, Miller ZA, Rosen HJ, Miller BL, et al. [IC-P-176]: TAU PATHOLOGY AND GRAY MATTER ATROPHY CONTRIBUTE TO COGNITIVE IMPAIRMENT IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P131-P131. DOI: 10.1016/J.Jalz.2017.06.2551  0.421
2017 Maass A, Lockhart SN, Mellinger TJ, Bell RK, Baker SL, Jagust WJ. [IC-P-124]: MEDIAL TEMPORAL LOBE TAU IS STRONGLY RELATED TO EPISODIC MEMORY DECLINE IN AGING Alzheimer's & Dementia. 13: P94-P95. DOI: 10.1016/J.Jalz.2017.06.2398  0.353
2017 La Joie R, Bourakova V, Visani A, Bejanin A, Ayakta N, Baker SL, Karydas A, Coppola G, Mensing A, Pham J, Rosen H, Miller BL, Jagust WJ, Rabinovici GD. [IC-P-059]: DOES APOE-ε4 HAVE AN Aβ-INDEPENDENT EFFECT ON TAU PATHOLOGY? NEUROIMAGING INVESTIGATIONS IN COGNITIVELY NORMAL ELDERS AND PATIENTS WITH ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P48-P49. DOI: 10.1016/J.Jalz.2017.06.2332  0.446
2017 Baker SL, Lockhart SN, Maass A, Jagust WJ. [P4-052]: PARTIAL VOLUME EFFECTS AND MEDIAL TEMPORAL LOBE TAU QUANTITATION WITH PET Alzheimer's & Dementia. 13: P1277-P1277. DOI: 10.1016/J.Jalz.2017.06.1917  0.391
2017 La Joie R, Visani A, Bourakova V, Baker SL, Ayakta N, Pham J, Mensing A, Rosen H, Miller BL, Jagust WJ, Rabinovici GD. [P2-373]: AV1451-PET CORTICAL UPTAKE AND REGIONAL DISTRIBUTION PREDICT LONGITUDINAL ATROPHY IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P769-P769. DOI: 10.1016/j.jalz.2017.06.1028  0.319
2017 La Joie R, Bourakova V, Visani A, Bejanin A, Ayakta N, Baker SL, Karydas A, Coppola G, Mensing A, Pham J, Rosen H, Miller BL, Jagust WJ, Rabinovici GD. [P1-031]: DOES APOE-ε4 HAVE AN Aβ-INDEPENDENT EFFECT ON TAU PATHOLOGY? NEUROIMAGING INVESTIGATIONS IN COGNITIVELY NORMAL ELDERS AND PATIENTS WITH ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P245-P246. DOI: 10.1016/j.jalz.2017.06.098  0.347
2016 Berry AS, Shah VD, Baker SL, Vogel JW, O'Neil JP, Janabi M, Schwimmer HD, Marks SM, Jagust WJ. Aging affects dopaminergic neural mechanisms of cognitive flexibility. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 27807030 DOI: 10.1523/Jneurosci.0626-16.2016  0.329
2016 Baker SL, Lockhart SN, Price JC, He M, Huesman RH, Schonhaut D, Faria J, Rabinovici G, Jagust WJ. Reference tissue-based kinetic evaluation of 18F-AV-1451 in aging and dementia. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27587706 DOI: 10.2967/Jnumed.116.175273  0.484
2016 Lockhart SN, Baker SL, Okamura N, Furukawa K, Ishiki A, Furumoto S, Tashiro M, Yanai K, Arai H, Kudo Y, Harada R, Tomita N, Hiraoka K, Watanuki S, Jagust WJ. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351. Plos One. 11: e0158460. PMID 27355840 DOI: 10.1371/Journal.Pone.0158460  0.497
2016 Oh H, Madison C, Baker S, Rabinovici G, Jagust W. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease. Brain : a Journal of Neurology. PMID 27190008 DOI: 10.1093/Brain/Aww108  0.42
2016 Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain : a Journal of Neurology. PMID 26962052 DOI: 10.1093/Brain/Aww027  0.517
2016 Schöll M, Lockhart SN, Schonhaut DR, O'Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD, Rabinovici GD, Jagust WJ. PET Imaging of Tau Deposition in the Aging Human Brain. Neuron. 89: 971-82. PMID 26938442 DOI: 10.1016/J.Neuron.2016.01.028  0.513
2016 Shokouhi S, Mckay JW, Baker SL, Kang H, Brill AB, Gwirtsman HE, Riddle WR, Claassen DO, Rogers BP. Reference tissue normalization in longitudinal (18)F-florbetapir positron emission tomography of late mild cognitive impairment. Alzheimer's Research & Therapy. 8: 2. PMID 26768154 DOI: 10.1186/S13195-016-0172-3  0.403
2016 Lockhart SN, Schöll M, Mellinger TJ, Swinnerton KN, Bell RK, O'Neil JP, Janabi M, Baker SL, Jagust WJ. O4-01-05: Examining Amyloid and Tau Inter-Regional Pet Association Patterns in Cognitively Normal Older Adults Alzheimer's & Dementia. 12: P332-P333. DOI: 10.1016/j.jalz.2016.06.610  0.303
2016 Ossenkoppele R, Schonhaut DR, Brown J, O'Neil JP, Janabi M, Baker SL, Schöll M, Kramer J, Gorno Tempini M, Miller B, Seeley WW, Jagust WJ, Rabinovici GD. O3-08-04: Tau Covariance Patterns in Alzheimer's Disease Patients Resemble Intrinsic Connectivity Networks in Young Adults Alzheimer's & Dementia. 12: P305-P306. DOI: 10.1016/J.Jalz.2016.06.552  0.365
2016 Lockhart SN, Schöll M, Mellinger TJ, Swinnerton KN, Bell RK, O'Neil JP, Janabi M, Baker SL, Jagust WJ. IC-P-193: Examining Amyloid and TAU Inter-Regional PET Association Patterns in Cognitively Normal Older Adults Alzheimer's & Dementia. 12: P139-P140. DOI: 10.1016/J.Jalz.2016.06.224  0.435
2016 Ossenkoppele R, Schonhaut DR, Brown J, O'Neil JP, Janabi M, Baker SL, Schöll M, Kramer J, Gorno Tempini M, Miller B, Seeley WW, Jagust WJ, Rabinovici GD. IC-P-192: TAU Covariance Patterns in ad Patients Resemble Intrinsic Connectivity Networks in Young Adults Alzheimer's & Dementia. 12: P138-P139. DOI: 10.1016/J.Jalz.2016.06.223  0.361
2016 Schonhaut DR, Ossenkoppele R, Bejanin A, Iaccarino L, Baker SL, Lazaris A, Cantwell A, Tammewar G, Ayakta N, Lockhart SN, Scholl M, O'Neil JP, Miller B, Jagust WJ, Rabinovici GD. IC-P-181: TAU-PET Patterns Overlap and Exceed Hypometabolism in Alzheimer's Disease Alzheimer's & Dementia. 12: P132-P133. DOI: 10.1016/j.jalz.2016.06.212  0.354
2016 Arenaza-Urquijo EM, Landau SM, Bell RK, Lockhart SN, Mellinger TJ, Baker SL, Chetelat G, Jagust WJ. IC-P-131: Normal Cognition Despite Very High Risk for Alzheimer’s Disease: Neuroimaging and Neuropsychological Insights Into Resilient Brain Aging Alzheimer's & Dementia. 12: P98-P99. DOI: 10.1016/J.Jalz.2016.06.161  0.347
2016 Schonhaut DR, Ossenkoppele R, Bejanin A, Iaccarino L, Baker SL, Lazaris A, Cantwell A, Tammewar G, Ayakta N, Lockhart S, Scholl M, O'Neil JP, Miller B, Jagust WJ, Rabinovici GD. P1-318: TAU-PET Patterns Overlap and Exceed Hypometabolism in Alzheimer's Disease Alzheimer's & Dementia. 12: P545-P547. DOI: 10.1016/J.Jalz.2016.06.1069  0.463
2015 Boutchko R, Mitra D, Baker SL, Jagust WJ, Gullberg GT. Clustering-initiated factor analysis application for tissue classification in dynamic brain positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 35: 1104-11. PMID 25899294 DOI: 10.1038/Jcbfm.2015.69  0.324
2015 Landau SM, Fero A, Baker SL, Koeppe R, Mintun M, Chen K, Reiman EM, Jagust WJ. Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 567-74. PMID 25745095 DOI: 10.2967/Jnumed.114.148981  0.441
2015 Ossenkoppele R, Schonhaut DR, Baker SL, O'Neil JP, Janabi M, Ghosh PM, Santos M, Miller ZA, Bettcher BM, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD. Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy. Annals of Neurology. 77: 338-42. PMID 25448043 DOI: 10.1002/Ana.24321  0.497
2015 Schöll M, Vogel JW, Schonhaut D, Lockhart S, Baker S, Schwimmer H, Ossenkoppele R, Rabinovici GD, Jagust WJ. Cognitive decline in healthy elderly is related to temporal lobe tau but not to cortical β-amyloid: An 18F-AV1451 and 11C-PiB PET study Alzheimers & Dementia. 11: 313-314. DOI: 10.1016/J.Jalz.2015.07.448  0.458
2015 Rabinovici GD, Schonhaut D, Baker S, Lazaris A, Ossenkoppele R, Lockhart S, Schöll M, Schwimmer H, Vogel JW, Ayakta N, Rosen H, Miller BL, O'Neil JP, Boxer AL, Jagust WJ. O4-01-06: Tau PET with [18 F]AV1451 in non-alzheimer's disease neurodegenerative syndromes Alzheimer's & Dementia. 11: P268-P269. DOI: 10.1016/j.jalz.2015.07.350  0.343
2015 Schonhaut D, Ossenkoppele R, Schöll M, Lockhart S, Baker S, Lazaris A, Cantwell A, Vogel JW, Ayakta N, Gorno-Tempini M, Miller ZA, O'Neil JP, Miller BL, Jagust WJ, Rabinovici GD. O4-01-02: Associations of [18 F]AV1451 Tau PET with age, ApoE genotype, and cognition in Alzheimer's disease Alzheimer's & Dementia. 11: P265-P266. DOI: 10.1016/j.jalz.2015.07.346  0.373
2015 Rabinovici GD, Schonhaut D, Baker S, Lazaris A, Ayakta N, Cantwell A, Lockhart S, Vogel JW, Schwimmer H, Schöll M, Gorno Tempini ML, Miller BL, Jagust WJ, Ossenkoppele R. F2-03-01: Tau and amyloid neuroimaging of ad phenotypes Alzheimer's & Dementia. 11: P167-P167. DOI: 10.1016/J.Jalz.2015.07.116  0.441
2015 Lockhart S, Schöll M, Schonhaut D, Ossenkoppele R, Vogel JW, Baker S, Schwimmer H, Rabinovici GD, Jagust WJ. Examining relations of age and beta-amyloid with tau deposition measured using 18F-AV-1451 in cognitively normal older adults Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.191  0.413
2015 Rabinovici GD, Schonhaut D, Baker S, Lazaris A, Ossenkoppele R, Lockhart S, Schöll M, Schwimmer H, Vogel JW, Ayakta N, Rosen H, Miller BL, O'Neil JP, Boxer AL, Jagust WJ. IC-P-161: Tau PET with [18 F]AV1451 in non-alzheimer's disease neurodegenerative syndromes Alzheimer's & Dementia. 11: P107-P109. DOI: 10.1016/J.Jalz.2015.06.184  0.462
2015 Schonhaut D, Ossenkoppele R, Schöll M, Lockhart S, Baker S, Lazaris A, Cantwell A, Vogel JW, Ayakta N, Gorno-Tempini M, Miller ZA, O'Neil JP, Miller BL, Jagust WJ, Rabinovici GD. IC-P-157: Associations of [18 F]AV1451 Tau PET with age, ApoE genotype, and cognition in Alzheimer's disease Alzheimer's & Dementia. 11: P105-P106. DOI: 10.1016/J.Jalz.2015.06.180  0.488
2015 Ossenkoppele R, Schonhaut D, Baker S, Lazaris A, Ayakta N, Cantwell A, Lockhart S, Vogel JW, Schwimmer H, Schöll M, Gorno Tempini ML, Miller BL, Jagust WJ, Rabinovici GD. IC-02-02: Distinct [18 F]AV1451 retention patterns in clinical variants of Alzheimer's disease Alzheimer's & Dementia. 11: P5-P6. DOI: 10.1016/J.Jalz.2015.06.008  0.391
2015 Schöll M, Schonhaut D, Lockhart S, Vogel JW, Baker S, Schwimmer H, Ossenkoppele R, Rabinovici GD, Jagust WJ. In vivo braak staging using 18F-AV1451 Tau PET imaging Alzheimers & Dementia. 11: 4. DOI: 10.1016/J.Jalz.2015.06.006  0.392
2014 Elman JA, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust WJ. Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability. Cerebral Cortex (New York, N.Y. : 1991). PMID 25405944 DOI: 10.1093/Cercor/Bhu259  0.382
2014 Elman JA, Oh H, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust WJ. Neural compensation in older people with brain amyloid-β deposition. Nature Neuroscience. 17: 1316-8. PMID 25217827 DOI: 10.1038/Nn.3806  0.359
2014 Landau SM, Thomas BA, Thurfjell L, Schmidt M, Margolin R, Mintun M, Pontecorvo M, Baker SL, Jagust WJ. Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers. European Journal of Nuclear Medicine and Molecular Imaging. 41: 1398-407. PMID 24647577 DOI: 10.1007/S00259-014-2753-3  0.468
2014 Ghosh PM, Madison C, Santos M, Norton K, Baker S, Boxer AL, Rosen HJ, Miller ZA, Gorno-Tempini M, Miller BL, Jagust W, Rabinovici GD. IC-P-023: AMYLOID PET HAS GREATER CLINICAL IMPACT THAN FDG PET IN THE DIFFERENTIAL DIAGNOSIS OF AD AND FTD Alzheimer's & Dementia. 10: P17-P18. DOI: 10.1016/J.Jalz.2014.05.027  0.422
2013 Oh H, Madison C, Baker S, Jagust W. Region-specific associations of brain glucose metabolism with age and beta-amyloid deposition in normal aging Alzheimers & Dementia. 9: 393. DOI: 10.1016/J.Jalz.2013.05.773  0.303
2013 Oh H, Madison C, Baker S, Jagust W. Region-specific associations of brain glucose metabolism with age and beta-amyloid in normal aging Alzheimers & Dementia. 9: 110. DOI: 10.1016/J.Jalz.2013.05.194  0.334
2012 Mormino EC, Brandel MG, Madison CM, Marks S, Baker SL, Jagust WJ. Aβ Deposition in aging is associated with increases in brain activation during successful memory encoding. Cerebral Cortex (New York, N.Y. : 1991). 22: 1813-23. PMID 21945849 DOI: 10.1093/Cercor/Bhr255  0.338
2012 Mormino EC, Brandel MG, Madison CM, Rabinovici GD, Marks S, Baker SL, Jagust WJ. Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage. 59: 1152-60. PMID 21884802 DOI: 10.1016/J.Neuroimage.2011.07.098  0.344
2011 Rosenbloom MH, Alkalay A, Agarwal N, Baker SL, O'Neil JP, Janabi M, Yen IV, Growdon M, Jang J, Madison C, Mormino EC, Rosen HJ, Gorno-Tempini ML, Weiner MW, Miller BL, et al. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology. 76: 1789-96. PMID 21525424 DOI: 10.1212/Wnl.0B013E31821Cccad  0.441
2011 Mormino EC, Smiljic A, Hayenga AO, Onami SH, Greicius MD, Rabinovici GD, Janabi M, Baker SL, Yen IV, Madison CM, Miller BL, Jagust WJ. Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging. Cerebral Cortex (New York, N.Y. : 1991). 21: 2399-407. PMID 21383234 DOI: 10.1093/Cercor/Bhr025  0.438
2011 Braskie MN, Landau SM, Wilcox CE, Taylor SD, O'Neil JP, Baker SL, Madison CM, Jagust WJ. Correlations of striatal dopamine synthesis with default network deactivations during working memory in younger adults. Human Brain Mapping. 32: 947-61. PMID 20578173 DOI: 10.1002/Hbm.21081  0.338
2010 Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, Baker SL, Agarwal N, Bonasera SJ, Mormino EC, Weiner MW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain : a Journal of Neurology. 133: 512-28. PMID 20080878 DOI: 10.1093/Brain/Awp326  0.452
2010 Rabinovici GD, Alkalay A, Rosen HJ, Furst AJ, Agarwal N, O'Neil JP, Jang JY, Growdon ME, Yen IV, Madison C, Baker SL, Gorno-Tempini ML, Seeley WW, Miller BL, Jagust WJ. IC-P-132: Comparison of [11C]PIB and [18F]FDG PET in Discriminating Alzheimer's Disease and Frontotemporal Lobar Degeneration Alzheimer's & Dementia. 6: S52-S53. DOI: 10.1016/J.Jalz.2010.05.147  0.447
2009 Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain : a Journal of Neurology. 132: 1310-23. PMID 19042931 DOI: 10.1093/Brain/Awn320  0.445
2009 Landau SM, Lal R, O'Neil JP, Baker S, Jagust WJ. Striatal dopamine and working memory. Cerebral Cortex (New York, N.Y. : 1991). 19: 445-54. PMID 18550595 DOI: 10.1093/Cercor/Bhn095  0.317
2008 Braskie MN, Wilcox CE, Landau SM, O'Neil JP, Baker SL, Madison CM, Kluth JT, Jagust WJ. Relationship of striatal dopamine synthesis capacity to age and cognition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 14320-8. PMID 19109513 DOI: 10.1523/Jneurosci.3729-08.2008  0.347
2007 Boxer AL, Rabinovici GD, Kepe V, Goldman J, Furst AJ, Huang SC, Baker SL, O'neil JP, Chui H, Geschwind MD, Small GW, Barrio JR, Jagust W, Miller BL. Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease. Neurology. 69: 283-90. PMID 17636066 DOI: 10.1212/01.Wnl.0000265815.38958.B6  0.452
2007 Rabinovici GD, Furst AJ, O'Neil JP, Racine CA, Mormino EC, Baker SL, Chetty S, Patel P, Pagliaro TA, Klunk WE, Mathis CA, Rosen HJ, Miller BL, Jagust WJ. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology. 68: 1205-12. PMID 17420404 DOI: 10.1212/01.Wnl.0000259035.98480.Ed  0.471
2006 Baker S, Baseler H, Klein S, Carney T. Localizing sites of activation in primary visual cortex using visual-evoked potentials and functional magnetic resonance imaging. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. 23: 404-15. PMID 17016150 DOI: 10.1097/01.Wnp.0000214596.69436.E0  0.635
2006 Teng E, Manser PT, Ward M, Sanabria-Bohorquez S, Ray R, Baker SL, Kerchner GA, Weimer R. P4-353: BASELINE TAU BURDEN MEASURED BY [18 F]GTP1 IMAGING IS ASSOCIATED WITH SUBSEQUENT COGNITIVE DECLINE IN PRODROMAL TO MILD ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P1604-P1605. DOI: 10.1016/j.jalz.2018.07.177  0.361
2006 Maass A, Berron D, Harrison TM, Baker SL, Mellinger TJ, Swinnerton KN, Bell RK, Düzel E, Jagust WJ. F1‐04‐04: EFFECTS OF TAU AND AMYLOID DEPOSITION MEASURED BY PET ON DOMAIN‐SPECIFIC MEMORY FUNCTION IN OLD AGE Alzheimer's & Dementia. 14. DOI: 10.1016/j.jalz.2018.06.2318  0.311
2006 La Joie R, Visani A, Lesman-Segev OH, Bourakova V, Baker SL, Janabi M, Miller ZA, O'Neil JP, Perry D, Pham J, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. IC-P-145: NON-AMNESTIC PHENOTYPES OF ALZHEIMER'S DISEASE, EARLY AGE OF ONSET AND APOE GENOTYPE ARE ASSOCIATED WITH TAU, NOT Aβ-PET Alzheimer's & Dementia. 14: P123-P124. DOI: 10.1016/J.Jalz.2018.06.2211  0.469
2006 Cha J, Park Y, Lee J, Baker SL, Visani A, Bourakova V, Pham J, Janabi M, O'Neil JP, Miller BL, Jagust WJ, Rabinovici GD. IC-P-136: MODELING AMYLOID, TAU, AND NEURODEGENERATION ACROSS THE ALZHEIMER'S DISEASE SPECTRUM: CROSS-SECTIONAL STUDY Alzheimer's & Dementia. 14: P113-P115. DOI: 10.1016/J.Jalz.2018.06.2202  0.388
2006 Winer JR, Mander BA, Helfrich RF, Maass A, Harrison TM, Baker SL, Knight RT, Jagust WJ, Walker MP. IC-P-131: HUMAN IN VIVO TAU PATHOLOGY, IMPAIRED NREM SLEEP OSCILLATIONS AND MEMORY DECLINE IN AGING Alzheimer's & Dementia. 14: P108-P109. DOI: 10.1016/J.Jalz.2018.06.2197  0.334
Show low-probability matches.